All past events – University of Copenhagen

2 June 2020, 14:00-17:00

INAMRSS/CeBIL Webinar Social Science Responses to Antimicrobial Resistance and COVID-19: New experiences to be gained and mutual lessons to be learned

Leading international AMR experts will explore the social science dimensions of antimicrobial resistance and the COVID-19 pandemic

» Read more

8 May 2020, 8:30

CeBIL co-organizes 2020 Petrie-Flom Center Conference at Harvard Law School

Innovation and Protection: The Future of Medical Device Regulation.

» Read more

27 Apr. 2020, 9:00

CeBIL co-organizes The International Regulators’ Roundtable on Artificial Intelligence Technologies in Health Care at Harvard Law School

Efforts, initiatives and challenges around the globe

» Read more

20 Feb. 2020, 16:00-17:00

Social Media Platforms as Public Health Arbiters: The Ethical and Legal Implications of Facebook's Suicide Detection Algorithm

Michael Lowery Wilson will talk on the ethical, cultural and jurisdictional landscape of medical surveillance as it pertains to
suicidal behavior and offer an opportunity to discuss the wider ramifications on society as a whole

» Read more

6 Nov. 2019, 8:00

How much is too much - Excessive Pharmaceutical Prices in European Competition Law & Regulation

Join the debate on excessive pricing of pharmaceuticals!

» Read more

6 Sept. 2019

CeBIL Annual Symposium 2019: Legal Innovation to Support the Development of Antimicrobial Drugs

This symposium explores the complex interactions between law and antimicrobial research and development

» Read more

12 June 2019, 8:30

CeBIL – RIBS Symposium: At the Cutting Edge: New Developments in the Law of Biomedicine

Symposium aims to address contemporaneous issues emerging in the field of biomedicine

» Read more

27 May 2019, 9:00

Governing Health 4.0: Legal and Ethical Considerations – US-European Perspectives

Five international scholars from a multidisciplinary background will share their insights and debate on this topic.

» Read more

8 May 2019, 12:00-13:00

Regulatory and intellectual property aspects of orphan drug innovation

What are the possibilities and hindrances in the European IPR and regulatory system for the continued development of orphan drugs?

» Read more

30 Apr. 2019, 12:00-13:00

Lunch Seminar with Prof. Ana Santos Rutschman

Topic: Healthcare Blockchain Infrastructure: A U.S. Case Study.

» Read more